Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ashley Yeo

Ashley Yeo is attached to the medtech titles within Informa’s Pharma intelligence division.

As Health Care editor on In Vivo (monthly hardcopy and online daily services), he writes and commissions news and feature material to meet the strategic business and market access information needs of senior players and device makers as they move innovations into the global medtech market place.

As part of the Principal Analyst team, he also contributes news delivery and insight needs across the group’s other medtech titles in the field of market access (global regulatory, reimbursement, policy changes). Key areas of focus are Germany, the UK and global themes, and EU and other outside global regulatory insight.

A linguist by training, he joined what was later to become Informa in mid-1988 as a French and German news reporter (with some other European languages also in the mix), and has been editor of three of the group’s titles (including Clinica) over a 14-year-period.

These duties are combined with supporting the growing Ask The Analyst service. He says: “This helps us as a group keep a close relationship with long-term and potential subscribers in a sector where insight and knowledge are key to our clients’ commercial success.”

Advertisement
Set Alert for Articles By Ashley Yeo

Latest From Ashley Yeo

New Mood Among UK IVDs As Ambitious Pathology Modernization Scheme Gathers Pace

NHS England's IVD and pathology sector is undergoing a major reorganization to make it fit for the future, responsive to growing demand and more patient-friendly. The plans are helping to change mindsets locally about how IVDs and pathology services should be delivered, according to speakers at a recent summit.

In Vitro Diagnostics United Kingdom

Brexit No Certain Thing For European Medtech Groups Desperate To Plan Futures

Medtech stakeholders were reminded at the UK's largest regulatory forum that, for business in general, and medical technology manufacturers in particular, those willing to make the best of Brexit are still having to work in the dark. The lack of useful government outreach is frustrating most efforts to secure business continuity. And that is without factoring in the huge regulatory changes that the EU's twin medical device regulations – the MDR and IVDR – will bring.

Brexit Market Access

Brexit + MDR Equals Little Certainty For UK And EU Medtech Groups

Medtech stakeholders were reminded recently at the UK's largest regulatory forum that even those willing to make the best of Brexit are still working in the dark. The lack of useful government outreach is frustrating most efforts to secure business continuity. And that is without factoring in the huge regulatory changes that the EU's twin medical device regulations – the MDR and IVDR – will bring.

Brexit Market Access

Philippines Gets Moving On Reg Reform: Asian Medtech Associations Regulatory Networking, October 2018

The Asian Medtech Associations Regulatory Networking discussions this month focus on regulatory reforms in the Philippines, where good progress is being made on embedding a new set of medical device, IVD and labeling regulations. Also, updates from Thailand, Hong Kong and India. This series is hosted by Medtech Insight, along with the Asia Regulatory and Quality Consultancy (ARQon) and the Asia Regulatory Professionals Association (ARPA).

Philippines India

UK's ABHI Marks 30 Years Of Championing HealthTech

The UK Association of British HealthTech Industries (ABHI) is marking three decades of supporting local medtech manufacturers and helping develop national and local health-care delivery infrastructures at its annual UK Market Conference in November.

United Kingdom Market Access

Alcon Selects Philips HealthSuite For Digital Platform Development

Royal Philips' HealthSuite digital platform has secured more industry partners to leverage the open, cloud-based infrastructure to provide services and facilitate connections to multiple diagnostic and surgical devices and data sources. Novartis' Alcon, and remote patient monitoring provider Integron, are the newest signatories to the platform.

Digital Health Ophthalmic
See All
Advertisement
UsernamePublicRestriction

Register